Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-25

Clinical Trial Results: A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety of a new inserter device for Paragard intrauterine copper contraceptive; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ParaGard (copper intrauterine device)

Snippet

Sponsor: CooperSurgical Inc. | Conditions: Contraception | Phase 4 | Status: COMPLETED | Results posted: 2026-08-25